We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 320

The Trans-Pacific Partnership at a glance
  • Baker & McKenzie
  • Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, USA, Vietnam
  • October 29 2015

The Trans Pacific Partnership ("TPP") is a free trade agreement which covers 40 of the world's economy, involving Australia, Brunei Darussalam

Australian gene patent decision may fly tasman
  • Chapman Tripp
  • Australia, New Zealand
  • October 21 2015

In a landmark judgment, Australia's highest court has declared that certain claims in a patent filed by a US company for a genetic product are not

What now for gene patents in Australia in light of D’Arcy v Myriad
  • Baldwins
  • Australia, New Zealand
  • October 15 2015

The highest court in Australia has unanimously ruled that isolated nucleic acids are not patentable subject matter, effectively reversing the status

The Trans-Pacific Partnership (TPP) and the cost of medicines in Australasia
  • Shelston IP Pty Ltd
  • Australia, New Zealand
  • October 6 2015

The Trans-Pacific Partnership (TPP) Free Trade Agreement (FTA) was agreed overnight in Atlanta. Involving 12 countries and potentially affecting up

Piggy-backing to market? TPP negotiations bring data exclusivity periods of biologics into public spotlight
  • Baldwins
  • Asia-Pacific, Australia, New Zealand, USA
  • September 7 2015

At the end of July 2015, media worldwide reported yet another stutter in the Trans-Pacific Partnership (TPP) trade negotiations. Especially prominent

An expensive lesson in licensing when exclusively performing an act does not make you an exclusive licensee
  • Baldwins
  • Australia, New Zealand
  • June 10 2015

It's generally well understood that in a number of jurisdictions an exclusive licensee can initiate infringement proceedings. However, the recent

Pharmaceutical patent term extension and data exclusivity in Australia, New Zealand and Asia: are you missing out?
  • Davies Collison Cave
  • Asia-Pacific, Australia, New Zealand
  • June 5 2015

Knowing the facts about patent term extension and data exclusivity will ensure you are not missing out on the protection your pharmaceutical product

Health alert (Australia) - 25 May 2015
  • DLA Piper LLP
  • Australia, New Zealand
  • May 25 2015

The Federal Court has held that an independent report upholding the Australian Medical Council's ('AMC') decision not to recognise 'cosmetic medical

Intellectual Property Laws Amendment Act 2015 update on recent changes to Australia’s intellectual property legislation
  • Davies Collison Cave
  • Australia, New Zealand
  • April 15 2015

The Intellectual Property Laws Amendment Act 2015 (Cth) received Royal Assent on 25 February 2015. Although some changes under the Act came into

IP in depth: patentable biotechnology a comparative analysis of key markets
  • Fisher Adams Kelly Callinans
  • Australia, European Union, New Zealand, USA
  • March 31 2015

There is extraordinary complexity and optimization underlying even comparatively 'simple' organisms. These powerful biological products and processes